The Commission For Protection Of Competition of the Republic of Serbia (“Commission“) recently announced that it will conduct a sectoral analysis of the pharmaceutical industry, specifically examining market conditions and competition in the human drug market in Serbia. This decision comes in light of increasing regulatory oversight and the need to assess competitive conditions in this key sector.

CMS has advised Laerdal Medical on its acquisition of SIMCharacters. Frotz Riedl reportedly advised the sellers.

MFW Fialek has advised Enterprise Investors on its acquisition of a majority stake in Salus Centrum Medyczne.

Bernitsas has advised CVC and Hellenic Healthcare Group on the disposal of a 60% stake in HHG to PureHealth Holding PJSC in a transaction that values HHG at EUR 2.2 billion.

Greenberg Traurig has advised Diagnostyka on its initial public offering and admission to trading on the regulated market of the Warsaw Stock Exchange. White & Case advised the underwriters. Baker McKenzie advised Diagnostyka's majority shareholder Mid Europa.

RTPR has advised the Integral Capital Group private equity fund on the acquisition of a majority stake in Embryos from the three founders of the business. Wolf Theiss advised the sellers.